Does 2.5mg Mounjaro actually do anything for weight loss?

2.5mg is licensed as a starter dose only — Eli Lilly designed it to reduce early side effects, not to deliver the weight-loss results seen in clinical trials.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, tested tirzepatide at therapeutic doses (5mg, 10mg and 15mg) (not at 2.5mg) and recorded average body-weight reductions of around 15–21% over 72 weeks.
Most prescribers titrate from 2.5mg to 5mg after approximately four weeks, provided the lower dose is well tolerated, that next step is where clinical benefit typically begins.
If you feel little appetite change on 2.5mg, that is normal; appetite suppression strengthens meaningfully as the dose increases toward the therapeutic range.

The 2.5mg dose of Mounjaro is not designed to produce significant weight loss. It is a tolerability dose — its job is to let your body adjust to tirzepatide before the real treatment begins. Most people wonder, quite reasonably, whether the starting pen is doing anything at all. The short answer is: not much yet, and that is exactly how it should be. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is right for you before any treatment is issued.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the first four weeks feel quiet, and what happens next

What is the 2.5mg dose actually for?

Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that regulate appetite and slow the rate at which the stomach empties. At 2.5mg, that activation is gentle. The dose was not included in SURMOUNT-1's efficacy analysis because Eli Lilly did not intend it as a therapeutic dose at all. The four-week starter period exists to give your digestive system time to adapt, which meaningfully reduces the nausea and stomach upset that can hit if someone jumps straight to a higher dose.

So if you are four weeks in and the scales have barely moved, please do not read that as failure. A question our prescribers hear regularly is whether the starter pen is working, and the honest answer is that it is working, just not on appetite yet. It is working on tolerability. That is a worthwhile job.

You can read a broader overview of how Mounjaro fits into a weight-management plan on our Mounjaro information page.

Does 2.5mg Mounjaro produce any weight loss at all?

A small amount of incidental weight loss is possible during the 2.5mg period, partly because people on any new weight-management programme tend to pay closer attention to food choices, and partly because even a modest slowing of gastric emptying can reduce snacking. But you should not expect the kind of results that clinical evidence associates with tirzepatide. The SURMOUNT-1 data, published in the New England Journal of Medicine, found average weight reductions of roughly 15–20% at the higher doses over 72 weeks, figures achieved by thousands of participants titrated well beyond the starter dose.

If someone tells you they lost substantial weight on 2.5mg alone, individual factors may be at play, but the population-level evidence simply does not support expecting that outcome at the starting dose. Managing expectations here protects you from unnecessary disappointment and from abandoning treatment before it has had a fair chance.

Whether the 2.5mg dose is doing enough for your specific situation is ultimately a clinical question; your prescriber will review your progress before recommending any titration step.

What happens after 2.5mg, and when does Mounjaro start working?

After roughly four weeks at 2.5mg, the standard path is an increase to 5mg, and this is where most people notice their appetite beginning to shift. Meals feel more filling, the urge to snack eases, and the habit of eating past fullness becomes easier to resist. The evidence around the 5mg dose is considerably stronger than at 2.5mg, and the step up is a meaningful clinical moment.

From 5mg the schedule continues in approximately four-week increments (7.5mg, 10mg, 12.5mg, 15mg) though titration speed and the dose you ultimately stay at depend on how well you tolerate each level and how your weight responds. Your prescriber reviews this before any increase; it is never automatic. For a closer look at how the timeline develops, this page on when 5mg begins to take effect walks through what to expect as the dose builds.

The NHS's patient information on tirzepatide gives a reliable overview of the dose schedule and what to discuss with your prescriber at each stage.

Is it worth continuing past the 2.5mg pen if you have not lost much weight yet?

Almost certainly yes, provided you are tolerating it. The whole point of the starter dose is to earn you access to the doses where the medicine does its real work. Stopping after the first pen because the scales have not moved is a bit like stopping a course of antibiotics after two days because you still feel unwell.

That said, if you are experiencing side effects severe enough to affect daily life, or if you have any concerns about how the medicine is sitting with you, that is a conversation for your prescriber rather than a reason to push through silently. Titration can be slowed; that is a clinical tool, not a defeat. You can also read about what to do if a dose delivery feels incomplete, since pen technique questions are common in the early weeks.

On cost: some people consider stopping early partly because of the expense of private treatment. Our guide to Mounjaro pricing in the UK gives honest context on what private treatment costs and what legitimate providers include. And if you are ready to talk to a prescriber about whether Mounjaro is right for you, starting a free consultation is the next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions